
‘Myasthenia gravis patients unresponsive to existing therapies need reimbursable new drugs'
Myasthenia gravis is a “chronic autoimmune neuromuscular disease” that is characterized as a wildfire that never knows where it will end up. It is a severe, rare, and life-threatening disease in which autoantibodies against proteins in the neuromuscular …